Introduction For this ThuRsday Tutorial, we’re going to cover something a bit different. Instead of showing how to do fairly simple epidemiological calculations, this edition will cover the first of
Author: Cody Micah Carmichael MPH, CPH
Top 5 Takeaways High HIV Prevalence: 38% of transgender women surveyed reported a positive HIV test, highlighting the group’s significant risk. Socioeconomic Challenges: Factors like low income, homelessness, and severe
Clinical trials, particularly randomized controlled trials (RCTs), are critical to evidence-based interventions, pharmaceutical testing, and public heatlh. They provide the most reliable data on the effectiveness of treatments, interventions, and
Top 5 Takeaways Widespread Health Impact: Following a petroleum leak at the Red Hill Bulk Fuel Storage Facility, 1,980 of 2,289 surveyed participants reported new or worsened health symptoms, indicating
Top 5 Takeaways Increased Risk with Subjective Cognitive Decline (SCD): Adults aged ≥45 with SCD are significantly more likely to report multiple risk factors for Alzheimer disease and related dementias
Top 5 Takeaways Increased Incidence of Post-COVID Conditions: Adults who survived COVID-19 are at a higher risk of developing conditions such as pulmonary embolism and respiratory symptoms, with 38% of
Top 5 Takeaways Widespread Outbreak: Early 2021 witnessed a multistate outbreak of listeriosis with 13 cases across four states, predominantly affecting Hispanic populations, leading to 12 hospitalizations and one death.
Top 5 Takeaways New Vaccine Option: JYNNEOS, a replication-deficient Vaccinia virus vaccine licensed in 2019, is now recommended by ACIP for preexposure prophylaxis against orthopoxviruses, offering an alternative to ACAM2000.
Top 5 Takeaways Increase in Group A Streptococcus Bacteremia: The University of Vermont Medical Center noted a substantial rise in cases of group A streptococcal bloodstream infections during 2022–2023, primarily
Top 5 Takeaways New Vaccination Recommendation: As of February 28, 2024, the Advisory Committee on Immunization Practices (ACIP) recommends an additional dose of the updated (2023–2024 Formula) COVID-19 vaccine for